Expression of Apoptosis-Controlling Proteins in Acute Leukemia Cells

References

• Reed J. C. Mini‐review: Cellular mechanisms of disease series. J Cell Biol 1994; 124: 1–6
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Smith S. D., Sklar J. Cloning and structural analysis of cDNAs for bcl‐2 and a hybrid bcl‐2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47: 19–28
   PubMed Web of Science ®Google Scholar
• Yang E., Korsmeyer S. J. Molecular thanatopsis: a discourse on the Bcl‐2 family and cell death. Blood 1996; 88: 386–401
   PubMed Web of Science ®Google Scholar
• Farrow S. N., Brown R. New members of the Bcl‐2 family and their protein partners. Current Opinion in Genetics. & Development 1996; 6: 45–49
   PubMed Web of Science ®Google Scholar
• Sedlak T. W., Oltvai Z. N., Yang E., Wang K., Boise L. H., Thompson C. B., Korsemcyer S. J. Multiple Bcl‐2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci 1995; 92: 7834–7838
   PubMed Web of Science ®Google Scholar
• Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl‐2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–619
   PubMed Web of Science ®Google Scholar
• Shimizu S., Eguchi Kamiike W., Matsuda H., Tsujimoto Y. Bcl‐2 expression prevents activation of the ICE protease cascade. Oncogene 1996; 12: 2251–2257
   PubMed Web of Science ®Google Scholar
• Golstein P. Controlling cell death. Science 1997; 275: 1081–1082
   PubMed Web of Science ®Google Scholar
• Alnemri E. S., Livingston D. J., Nicholson D. W., Salvesen G., Thornberry N. A., Wong W. W., Yuan J. Human ICE/CED‐3 Protease nomenclature. Cell 1996; 87: 171
   PubMed Web of Science ®Google Scholar
• Patel T., Gores G. J., Kaufmann S. H. The role of proteases during apoptosis. FASEB 1996; 10: 587–597
   PubMed Web of Science ®Google Scholar
• Cerretti D. P., Kozlosky C. J., Mosley B., Nelson N., Ness K. V., Greenstreet T. A., March C. J., Kronheim S. R., Druck Cannizzaro L.A., Huebner K., Black R. A. Molecular cloning of the Interleukin‐IB Converting Enzyme. Science 1992; 256: 97–100
   PubMed Web of Science ®Google Scholar
• Wang L., Miura M., Bergeron L., Zhu H., Yuan J. lch‐1, an lce/ced‐3‐related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739–750
   PubMed Web of Science ®Google Scholar
• Fernandes‐Alnemri T., Litwach G., Alnemri E. S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced‐3 and mammalian interleukin‐1 beta‐converting enzyme. J Biol Chem 1994; 269: 30761–30764
   PubMed Web of Science ®Google Scholar
• Zutter M., Hockenbery D., Silverman G. A., Korsemeyer S. J. Immunolocalization of the bcl‐2 protein within hematopoietic neoplasms. Blood 1991; 78: 1062–1068
   PubMed Web of Science ®Google Scholar
• Pettersson M., Jernberg‐Wiklund H., Larsson L. G., Sund‐ström C., Givol I., Tsujimoto Y., Nilsson K. Expression of the bcl‐2 gene in human multiple myeloma cell lines and normal plasma cells. Blood 1992; 79: 495–502
   PubMed Web of Science ®Google Scholar
• Krajewski S., Bodrug S., Gascoyne R., Berean K., Krajew‐ska M., Reed J. C. Immunohistochemical analysis of mcl‐1 and bcl‐2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994; 145: 515–525
   PubMed Web of Science ®Google Scholar
• Delia D., Aiello A., Soligo D., Fontanella E., Melani C., Pezzella E., Pierotti M. A., Delia Porta G. bcl‐2 proto‐oncogene expression in normal and neoplastic human myeloid cells. Blood 1992; 79: 1291–1298
   PubMed Web of Science ®Google Scholar
• Steube K. G., Jadau A., Teepe D., Drexler H. G. Expression of bcl‐2 mRNA and protein in leukemia‐lym‐phoma cell lines. Leukemia 1995; 9: 1841–1846
   PubMed Web of Science ®Google Scholar
• Campos L., Rouault J. P., Sabido O., Oriol P., Roubi N., Archimbaud E., Vasselon C., Magaud J. P., Guyotat D. High expression of bcl‐2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993; 81: 3091–3096
   PubMed Web of Science ®Google Scholar
• Campos L., Sabido O., Magaud J. P., Bertheas M. F., Char‐tin C., Sebban C., Guyotat D. Expression of BCL2 proto‐oncogene in acute lymphoblastic leukemia cells. Leukemia 1996; 10: 434–438
   PubMed Web of Science ®Google Scholar
• Maung Z. T., MacLean F. R., Reid M. M., Pearson A. D. J., Proctor S. J., Hamilton P. J., Hall A. G. The relationship between bcl‐2 expression and response to chemotherapy in acule leukemia. Br J Haematol 1994; 88: 105–109
   PubMed Web of Science ®Google Scholar
• Brousset P., Benharroch D., Krajewski S., Laurent G., Meggetto R., Rigal‐Huet E., Gopas J., Prinsloo I., Pris J., Delsol G., Reed J. C., Schlaifer D. Frequent expression of the cell death‐inducing gene Bax in Reed‐Sternberg culls of Hodgkin's disease. Blood 1996; 87: 2470–2475
   PubMed Web of Science ®Google Scholar
• Schlaifer D., Krajewski S., Galoin S., Rigal‐Huguet E., Laurent G., Massip P., Pris J., Delsol G., Reed J. C., Brousset P. Immunodetection of apoptosis‐regulat‐ing proteins in lymphomas from patients with and without Human Immunodeficiency Virus infection. Am J Pathol 1996; 149: 177–185
   PubMed Web of Science ®Google Scholar
• Stoetzer O. J., Nussler V., Darsow M., Gullis E., Pelka‐Fleischer R., Scheel U., Wilmanns W. Association of bcl‐2, bax, bcl‐xL and interleukin‐1 β‐converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. Leukemia 1996; 10: S18–S22, Suppl
   PubMed Web of Science ®Google Scholar
• Estrov Z., Black R., Sleath P. R., Harris D., Van Q., LaPushin R., Estey E. H., Talpaz M. Effect of interleukin‐1 β converting enzyme inhibitor on acute myeloge‐nous leukemia progenitor proliferation. Blood 1995; 86: 4594–4602
   PubMed Web of Science ®Google Scholar
• Itias M., Tomlinson I. P. M., Hanby A. M., Yao T., Bodraer W. F., Talbot I. C. Bcl‐2 expression in colorectal tumors:. Am J Pathol. 1996; 149: 1719–1726
   PubMed Web of Science ®Google Scholar
• Krajewska M., Fenoglio‐Preiser C. M., Krajewski S., Song K., Macdonald J. S., Stemmerman G., Reed J. C. Immunohistochemical analysis of Bcl‐2 family proteins in adenocarcinoma of the stomach. Am J Pathol 1996; 49: 1449–1457
   Google Scholar
• Krajewski S., Krajewska M., Ehrmann J., Sikorska M., Lach B., Chatten J., Reed J. C. Immunohistochemical analysis of Bcl‐2, Bcl‐X, Mcl‐1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol 1997; 150: 805–814
   PubMed Web of Science ®Google Scholar
• Krajewska M., Krajewski S., Epstein J. I., Shabaik A., Sau‐vageot J., Song K., Kitada S., Reed J. C. Immunohistochemical analysis of bcl‐2, bax, bcl‐X. and mcl‐1 expression in prostate cancers. Am J Pathol 1996; 148: 1567–1576
   PubMed Web of Science ®Google Scholar
• Brambilla E., Negoescu A., Gazzeri S., Lantuejoul S., Moro D., Brambilla C., Coll J. L. Apoptosis‐related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol 1996; 149: 1941–1952
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Gal‐ton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med. 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Groeneveld K., le Marvelde J. G., van den Beemd M. W. M., Hooijkaas H., van Dongen J. I. M. Flow cytometry detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia 1996; 10: 1383–1389
   PubMed Web of Science ®Google Scholar
• Bene M. C., Castoldi G., Knapp W., Ludwig W. D., Mat‐utes E., Orfao A., van't Veer M. B. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783–1786
   PubMed Web of Science ®Google Scholar
• Boise L. H., Gonzalez‐Garcia M., Postena C. E., Lindstren T., Turka L. A., Mao X., Nunez G., Thompson C. B. Bcl‐x, a bcl‐2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993; 74: 597–608
   PubMed Web of Science ®Google Scholar
• Sato T., Hanada M., Bodrug S., Iric S., Iwama N., Boise L., Thomson C., Golemis E., Fong L., Wang H., Reed J. Interactions among meinbers of the Bcl‐2 protein family with a yeast two hybrid system. Proc Natl Acad Sci 1994; 9: 9238–9242
   Web of Science ®Google Scholar
• Dole M. G., Clarke M. F., Holman P., Benedict M., Lu J., Jasty R., Eipers P., Thompson C. B., Rode C., Bloch C., Nunez G., Castle V. P. Bcl‐xS enhances adenoviral vector‐induced apoptosis in neuroblastoma cells. Cancer Res 1996; 56: 5734–5740
   PubMed Web of Science ®Google Scholar
• Sumantran V. N., Ealovega M. W., Nunez G., Clarke M. F., Wicha M. S. Overexpression of Bcl‐xS sensitizes MCF‐7 cells to chemotherapy‐induced apoptosis. Cancer Res 1995; 55: 2507–2510
   PubMed Web of Science ®Google Scholar
• Krajewski S., Blomqvist C., Franssila K., Krajewska M., Wasenius V. M., Niskanen E., Nordling S., Reed J. C. Reduced expression of proapoptotic gene BAX is associated with poor reponse rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 1995; 55: 4471–4478
   PubMed Web of Science ®Google Scholar
• Bellosillo B., Dalmau M., Colomer D., Gil J. Involvement of CED‐3/ICE proteases in the apoptosis of B‐chronic lymphocytic leukemia cells. Blood 1997; 89: 3378–3384
   PubMed Web of Science ®Google Scholar
• Yoshida A., Takauji R., Inuzuka M., Nakamura T. Role of serine and ICE‐like proteases in induction of apoptosis by etoposide in human leukemia IIL‐60 cell. Leukemia 1996; 10: 821–824
   PubMed Web of Science ®Google Scholar
• Krajewski S., Gascoyne R. D., Zapata J. M., Krajewska M., Kitada S., Chhanabhai M., Horsman D., Berean K., Piro L. D., Fugier‐Vivier I., Liu Y. J., Wang H. G., Reed J. C. Immunolocalization of the ICE/Ced‐3‐family protease, CPP32 (Caspase‐3), in Non‐Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph‐nodes. Blood 1997; 89: 3817–3825
   PubMed Web of Science ®Google Scholar
• Lowenberg B., van Putten W. L. J., Touw I. P., Delwel R., Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. New Engl J Med 1993; 328: 614–619
   PubMed Web of Science ®Google Scholar